Skip to content

Clinical efficacy of huolong cupping comprehensive moxibustion therapy for spontaneous sweating of qi deficiency syndrome: A randomized controlled trial

2022 New Services & Technologies Initiatives Henan Provincial People's Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001079
Enrollment
Unknown
Registered
2025-05-29
Start date
2022-06-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperhidrosis

Interventions

experimental group:huolong cupping comprehensive moxibustion therapy
control group:health education

Sponsors

HENAN PROVINCIAL PEOPLE'S HOSPITAL
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria of Traditional Chinese Medicine and symptom diagnosis standards; 2.Be between the ages of 18 and 60; 3.Sign an informed consent form and voluntarily participate in the study.

Exclusion criteria

Exclusion criteria: 1.Individuals with skin diseases or local skin infections ulcers at the treatment site; 2.Those who are using traditional Chinese medicine to treat qi deficiency with spontaneous sweating or using local antiperspirants anticholinergic drugs or other medications that affect sweating; 3.Individuals with severe liver or kidney dysfunction such as: severe liver damage liver cirrhosis or other serious liver diseases severe renal failure dialysis or other serious kidney diseases; 4.Individuals with serious heart disease (such as heart failure myocardial infarction) severe cerebrovascular disease (such as stroke) or other serious cardiovascular and cerebrovascular diseases; 5.Individuals with severe blood diseases abnormal blood coagulation or other serious hematopoietic system diseases leading to coagulation dysfunction; 6.Individuals with hyperhidrosis caused by other clear diseases such as pulmonary tuberculosis hyperthyroidism central nervous system damage etc.; 7.Pregnant lactating and perinatal women; 8.Patients with cognitive dysfunction and psychological disorders; 9.Individuals who are prone to allergies to moxa smoke.

Design outcomes

Primary

MeasureTime frame
Traditional Chinese Medicine Syndrome Scoring;

Secondary

MeasureTime frame
Quality of Life;

Countries

China

Contacts

Public ContactHui Peng

HENAN PROVINCIAL PEOPLE'S HOSPITAL

631712992@qq.com16638107768

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026